Dr Lim Yujing

Dr Lim Yujing

Dr Lim Yujing is the Chief Executive Officer & Chief Technology Officer at Osteopore, a global medical device company that adopted 3D printing technology to manufacture bioresorbable scaffolds for bone regeneration. He has spent more than a decade in Osteopore, observing growth from a 2-man team to an organisation with offices in Singapore, Australia, and South Korea.

Osteopore has ~20 years and more than 140,000 successful examples of clinical history in bone regeneration. We started first in the craniofacial region before expanding applications to dental / oralmaxillofacial surgery, reconstructive rhinoplasty, and orthopaedic surgery.

He has been with the organisation for more than a decade, and started leading the organisation since July 2023. Prior to that, he guided the company through successful regulatory and quality milestones such as ISO 13485, Korea GMP audits and FDA inspections; CE Marking. He also led product expansion initiatives, along with maintaining control over the company’s overall operational effectiveness.

He is passionate about providing safe and effective implants for patients, and believes that devices with unique technology can be made beneficial to the stakeholders of our healthcare system: hospitals, surgeons (doctors), and patients. His unique academic background as a mechanical engineer (Masters) and biomedical engineer (PhD) provides him with a strong foundation to innovate and cocreate with clinicians, and drive impact in the medical device industry.